Mycobacterium tuberculosis immunization
US7022320B1 · kind B1 · utility
0Cited by
33References
33Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 9, 2000 |
| Grant date | Apr 4, 2006 |
| Priority date | — |
| Expiry date | Feb 9, 2020 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S435/863
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Recombinant nucleic acid molecules are described. The molecules have a sequence or sequences encoding at least two M. tuberculosis antigens. Vectors and compositions containing these molecules are also described. In addition, compositions containing a cocktail of recombinant nucleic acid molecules having a sequence or sequences encoding one or more M. tuberculosis antigens are described. Methods of eliciting an immune response using these molecules and compositions are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.